Both in Pharmaceuticals
Nuvectis Pharma vs Bicara Therapeutics
Over the past year NVCT returned +214.1% and BCAX returned −39.7%; their daily moves had a correlation of 0.14.
NVCT +214.1% BCAX −39.7%Growth of $1, one year, split-adjusted
| Metric | NVCT | BCAX |
|---|---|---|
| Price | $18.47 | $8.89 |
| Market cap | $602.9M | $588.3M |
| Today | −4.50% | −0.78% |
| 1 month | −7.8% | −46.3% |
| 6 months | +84.7% | −62.6% |
| Year to date | +144.6% | −47.2% |
| 1 year | +190.4% | −44.4% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $22.2M | $497.3M |
| Dividend yield | — | — |
| Volatility (60d) | 68.4% | 131.9% |
| Short % of float | 11.7% | 23.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).